Valuation: StimCell Energetics Inc.

Market Cap 46.51L 40.32L 38.1L 34.52L 64.75L 45Cr 65.26L 4.55Cr 1.75Cr 23Cr 1.75Cr 1.71Cr 72Cr P/E 2027 *
-11x
P/E 2028 * -
Enterprise Value 54.51L 47.25L 44.65L 40.46L 75.89L 52Cr 76.49L 5.33Cr 2.05Cr 26Cr 2.05Cr 2Cr 85Cr EV / Sales 2027 *
-
EV / Sales 2028 * 9.09x
Free-Float
28.33%
Yield 2027 *
-
Yield 2028 * -
1 week+8.21%
Current month+37.73%
1 month+1.00%
3 months-12.77%
6 months+0.97%
Current year-24.25%
1 month 0.18
Extreme 0.18
0.3
Current year 0.18
Extreme 0.18
0.48
1 year 0.18
Extreme 0.18
0.48
3 years 0
Extreme 0.0015
3.42
5 years 0
Extreme 1.4E-5
13.97
10 years 0
Extreme 1.4E-5
25.35
Manager TitleAgeSince
Chief Executive Officer 56 12/12/2023
Director of Finance/CFO 48 24/11/2014
Director TitleAgeSince
Chairman 74 26/02/2024
Director/Board Member 62 08/06/2020
Director/Board Member 56 12/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
18/12/25 Sell

Director

16,667 0.0807%
17/03/25 Tax

Director

6,08,41,472 -
25/02/25 Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+8.21%+12.22%-45.41% 46.51L
+0.56%-4.17%-1.90%+9.79% 4.56TCr
-0.12%-2.46%+340.09%+529.37% 4.4TCr
+1.51%+0.71%+44.04%+26.63% 4.37TCr
-2.07%-3.28%+6.83%+74.56% 4.02TCr
-0.73%-4.72%+8.55%+37.89% 3.19TCr
-9.49%-11.38% - - 1.74TCr
+4.21%+4.94%+26.46%+121.58% 1.66TCr
+1.83%+2.63%+15.14%+33.31% 1.45TCr
-0.08%-5.41%+78.48%+31.34% 1.3TCr
Average +0.38%-1.63%+58.88%+91.01% 2.67TCr
Weighted average by Cap. +0.19%-2.09%+76.22%+128.25%

Financials

2027 *2028 *
Net sales - 6L 5L 5L 4L 8L 5.75Cr 8L 58.64L 22.56L 2.92Cr 22.54L 22.04L 9.31Cr
Net income -5L -4L -4L -4L -7L -4.89Cr -7L -49.85L -19.18L -2.48Cr -19.16L -18.73L -7.91Cr -
Net Debt 8L 7L 7L 6L 11.14L 7.67Cr 11.23L 78.19L 30.09L 3.89Cr 30.05L 29.38L 12Cr 8L 7L 7L 6L 11.14L 7.67Cr 11.23L 78.19L 30.09L 3.89Cr 30.05L 29.38L 12Cr
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STME Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!